{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:16:30Z","timestamp":1790914590419,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Malaya Research Grant","award":["RG506-13HTM"],"award-info":[{"award-number":["RG506-13HTM"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>New-onset diabetes after transplantation (NODAT) is associated with reduced patient and graft survival. This study examined the clinical and selected genetic factors associated with NODAT among renal-transplanted Malaysian patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included 168 non-diabetic patients (58% males, 69% of Chinese ethnicity) who received renal transplantation between 1st January 1994 to 31st December 2014, and were followed up in two major renal transplant centres in Malaysia. Fasting blood glucose levels were used to diagnose NODAT in patients who received renal transplantation within 1 year. Two single nucleotide polymorphisms (SNPs), namely; rs1494558 (interleukin-7 receptor, IL-7R) and rs2232365 (mannose-binding leptin-2, MBL2) were selected and genotyped using Sequenom MassArray platform. Cox proportional hazard regression analyses were used to examine the risk of developing NODAT according to the different demographics and clinical covariates, utilizing four time-points (one-month, three-months, six-months, one-year) post-transplant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventeen per cent of patients (<jats:italic>n<\/jats:italic>\u2009=\u200929, 55% males, 69% Chinese) were found to have developed NODAT within one-year of renal transplantation based on their fasting blood glucose levels. NODAT patients had renal transplantation at an older age compared to non-NODAT (39.3\u2009\u00b1\u200913.4 vs 33.9\u2009\u00b1\u200911.8\u2009years,<jats:italic>p<\/jats:italic>\u2009=\u20090.03). In multivariate analysis, renal-transplanted patients who received a higher daily dose of cyclosporine (mg) were associated with increased risk of NODAT (Hazard ratio (HR) =1.01 per mg increase in dose, 95% confidence interval (CI) 1.00\u20131.01,<jats:italic>p<\/jats:italic>\u2009=\u20090.002). Other demographic (gender, ethnicities, age at transplant) and clinical factors (primary kidney disease, type of donor, place of transplant, type of calcineurin inhibitors, duration of dialysis pre-transplant, BMI, creatinine levels, and daily doses of tacrolimus and prednisolone) were not found to be significantly associated with risk of NODAT. GA genotype of rs1494558 (HR\u2009=\u20093.15 95% CI 1.26, 7.86) and AG genotype of rs2232365 (HR\u2009=\u20092.57 95% CI 1.07, 6.18) were associated with increased risk of NODAT as compared to AA genotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The daily dose of cyclosporine and SNPs of IL-7R (rs1494558) and MBL2 (rs2232365) genes are significantly associated with the development of NODAT in the Malaysian renal transplant population.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-020-02052-9","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T13:02:47Z","timestamp":1599483767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-3760","authenticated-orcid":false,"given":"Rhanye Mac","family":"Guad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Taylor-Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan Seng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Hua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Lisa","family":"Zaharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma Choudhury","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance Sat Lin","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Ahmad Hafiz","family":"Wan Md Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"2052_CR1","first-page":"133","volume-title":"Living donor organ transplantation","author":"LH Toledo-Pereyra","year":"2008","unstructured":"Toledo-Pereyra LH, Toledo AH. History of living donor kidney transplantation. In: Living donor organ transplantation; 2008. p. 133."},{"key":"2052_CR2","doi-asserted-by":"publisher","first-page":"107948","DOI":"10.1016\/j.diabres.2019.107948","volume":"159","author":"S Kumar","year":"2020","unstructured":"Kumar S, Sanyal D, Das P, Bhattacharjee K, Rungta R. An observational prospective study to evaluate the outcomes of new-onset diabetes after renal transplantation (NODAT) in a tertiary care Centre in eastern India. Diabetes Res Clin Pract. 2020;159:107948.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2052_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.1996.307","volume":"50","author":"A Laupacis","year":"1996","unstructured":"Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50(1):235\u201342.","journal-title":"Kidney Int"},{"issue":"4","key":"2052_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/ctr.12510","volume":"29","author":"JJ Gaynor","year":"2015","unstructured":"Gaynor JJ, Ciancio G, Guerra G, Sageshima J, Hanson L, Roth D, et al. Multivariable risk of developing new onset diabetes after transplant\u2014results from a single-center study of 481 adult, primary kidney transplant recipients. Clin Transpl. 2015;29(4):301\u201310.","journal-title":"Clin Transpl"},{"issue":"8","key":"2052_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1440-1797.2008.01052.x","volume":"13","author":"KM Chow","year":"2008","unstructured":"Chow KM, LI PKT. Review article: new-onset diabetes after transplantation. Nephrology. 2008;13(8):737\u201344.","journal-title":"Nephrology."},{"key":"2052_CR6","first-page":"175","volume":"4","author":"P-TT Pham","year":"2011","unstructured":"Pham P-TT, Pham P-MT, Pham SV, Pham P-AT, Pham P-CT. New onset diabetes after transplantation (NODAT): an overview. Diabetes, metabolic syndrome and obesity: targets and. Therapy. 2011;4:175.","journal-title":"Therapy."},{"issue":"1","key":"2052_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147323","volume":"11","author":"KA Benson","year":"2016","unstructured":"Benson KA, Maxwell AP, McKnight AJ. A HuGE review and meta-analyses of genetic associations in new onset diabetes after kidney transplantation. PLoS One. 2016;11(1):e0147323.","journal-title":"PLoS One"},{"issue":"5","key":"2052_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1046\/j.1365-2265.2000.01132.x","volume":"53","author":"KC Chiu","year":"2000","unstructured":"Chiu KC, Lee NP, Cohan P, Chuang LM. Beta cell function declines with age in glucose tolerant Caucasians. Clin Endocrinol (Oxf). 2000;53(5):569\u201375.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2052_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0b013e3182497534","volume":"93","author":"YG Kim","year":"2012","unstructured":"Kim YG, Ihm C-G, Lee TW, Lee SH, Jeong KH, Moon JY, et al. Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation. Transplantation. 2012;93(9):900\u20137.","journal-title":"Transplantation."},{"issue":"8","key":"2052_CR10","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1681\/ASN.2007030262","volume":"18","author":"SP Berger","year":"2007","unstructured":"Berger SP, Roos A, Mallat MJ, Schaapherder AF, Doxiadis II, van Kooten C, et al. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol. 2007;18(8):2416\u201322.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2052_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00109-004-0623-3","volume":"83","author":"M Boniotto","year":"2005","unstructured":"Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, et al. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J Mol Med. 2005;83(4):308\u201315.","journal-title":"J Mol Med"},{"key":"2052_CR12","unstructured":"13th Report of the of the National Transplant Registry 2016. Available at: http:\/\/www.mst.org.my\/ntrSite\/publications_13thReport2016.htm. Accessed on 18 Nov 2019."},{"key":"2052_CR13","unstructured":"Institute for Public Health 2020. National Health and Morbidity Survey (NHMS) 2019: Non-communicable diseases, healthcare demand and health literacy- Key Findings. Institure for Public Health, National Institute of Health Malaysia, Ministry of Health Malaysia. 2020. http:\/\/iku.moh.gov.my\/images\/IKU\/Document\/REPORT\/NHMS2019\/Infographic_Booklet)NHMS_2019-English.pdf. Accessed on 15 Aug 2020."},{"issue":"06","key":"2052_CR14","first-page":"44","volume":"3","author":"SW Lai","year":"2013","unstructured":"Lai SW, Chong CP, Abdul AN. Evaluating the incidence, risk factors and glycaemic control of new-onset diabetes mellitus in kidney transplant recipients: a single Centre study. J Appl Pharmaceutical Sci. 2013;3(06):44\u201351.","journal-title":"J Appl Pharmaceutical Sci"},{"issue":"7","key":"2052_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.transproceed.2004.08.118","volume":"36","author":"SM Foo","year":"2004","unstructured":"Foo SM, Wong HS, Morad Z. Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients. Transplant Proc. 2004;36(7):2139\u201340.","journal-title":"Transplant Proc"},{"issue":"10","key":"2052_CR16","first-page":"SS3","volume":"75","author":"J Davidson","year":"2003","unstructured":"Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation. 2003;75(10):SS3\u201324.","journal-title":"Transplantation."},{"issue":"1","key":"2052_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-6386(99)70101-0","volume":"34","author":"MR Weir","year":"1999","unstructured":"Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34(1):1\u20133.","journal-title":"Am J Kidney Dis"},{"key":"2052_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/NDT.S231352","volume":"16","author":"H Zhu","year":"2020","unstructured":"Zhu H, Zhang M, Fu Y, Long H, Xiao W, Feng L, et al. Effects of AQP4 and KCNJ10 gene polymorphisms on drug resistance and seizure susceptibility in Chinese Han patients with focal epilepsy. Neuropsychiatr Dis Treat. 2020;16:119.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"2052_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4239\/wjd.v9.i7.132","volume":"9","author":"V Gomes","year":"2018","unstructured":"Gomes V, Ferreira F, Guerra J, Bugalho MJ. New-onset diabetes after kidney transplantation: incidence and associated factors. World J Diabetes. 2018;9(7):132.","journal-title":"World J Diabetes"},{"issue":"6","key":"2052_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.20945\/2359-3997000000084","volume":"62","author":"C Lima","year":"2018","unstructured":"Lima C, Grden A, Skare T, Jaworski P, Nisihara R. Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study. Arch Endocrinol Metab. 2018;62(6):597\u2013601.","journal-title":"Arch Endocrinol Metab"},{"issue":"8","key":"2052_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.arcmed.2006.05.004","volume":"37","author":"J Andrade-Sierra","year":"2006","unstructured":"Andrade-Sierra J, Contreras AM, Monteon FJ, Celis A, Gutierrez R, Monta\u00f1ez JL, et al. Mexican cooperative Group for the Study of hepatitis in kidney diseases. Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients. Arch Med Res. 2006;37(8):961\u20136.","journal-title":"Arch Med Res"},{"issue":"4","key":"2052_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jegh.2016.03.004","volume":"6","author":"R Begum","year":"2016","unstructured":"Begum R, Khan TM, Ming LC. Burden of chronic kidney disease and its risk factors in Malaysia. J Epidemiol Global Health. 2016;6(4):325\u20136.","journal-title":"J Epidemiol Global Health"},{"issue":"1","key":"2052_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12882-016-0321-8","volume":"17","author":"H Yu","year":"2016","unstructured":"Yu H, Kim H, Baek CH, Baek SD, Jeung S, Han DJ, et al. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea-a retrospective single center study. BMC Nephrol. 2016;17(1):106.","journal-title":"BMC Nephrol"},{"issue":"5","key":"2052_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00125-018-4544-z","volume":"61","author":"L Huo","year":"2018","unstructured":"Huo L, Magliano DJ, Ranci\u00e8re F, Harding JL, Nanayakkara N, Shaw JE, et al. Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997\u20132011. Diabetologia. 2018;61(5):1055\u201363.","journal-title":"Diabetologia."},{"issue":"1","key":"2052_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-1440-2-1","volume":"2","author":"EH Cole","year":"2013","unstructured":"Cole EH, Prasad GR, Cardella CJ, Kim JS, Tinckam KJ, Cattran DC, et al. A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients. Transplant Res. 2013;2(1):1.","journal-title":"Transplant Res"},{"issue":"25","key":"2052_CR26","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, V\u00edtko \u0160, Nashan B, G\u00fcrkan A, et al. Reduced exposure to Calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357(25):2562\u201375.","journal-title":"N Engl J Med"},{"issue":"10","key":"2052_CR27","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1016\/j.transproceed.2018.08.037","volume":"50","author":"A Zolota","year":"2018","unstructured":"Zolota A, Miserlis G, Solonaki F, Tranda A, Antoniadis N, Imvrios G, et al. New-onset diabetes after transplantation: comparison between a cyclosporine-based and a Tacrolimus-based immunosuppressive regimen. Transplant Proc. 2018;50(10):3386\u201391.","journal-title":"Transplant Proc"},{"key":"2052_CR28","doi-asserted-by":"crossref","unstructured":"Szili-Torok T, Annema W, Anderson JL, Bakker SJ, Tietge UJ. High Density Lipoprotein Cholesterol Efflux Predicts Incident New Onset Diabetes After Transplantation (NODAT) in Renal Transplant Recipients Independent of High Density Lipoprotein Cholesterol Levels. Diabetes. 2019:db181267.","DOI":"10.2337\/db18-1267"},{"key":"2052_CR29","doi-asserted-by":"crossref","unstructured":"Saigi-Morgui N, Quteineh L, Bochud PY, Crettol S, Kutalik Z, Mueller NJ, Binet I, Van Delden C, Steiger J, Mohacsi P, Dufour JF. Genetic and clinic predictors of new onset diabetes mellitus after transplantation. Pharmacogenomics J. 2019;19 (1):53-64.","DOI":"10.1038\/s41397-017-0001-5"},{"key":"2052_CR30","doi-asserted-by":"crossref","unstructured":"Nepali R, Shah DS. New onset diabetes after transplant in renal transplant recipients. J Inst Med. 2017;39(1):82\u20135.","DOI":"10.59779\/jiomnepal.740"},{"key":"2052_CR31","first-page":"11","volume":"34","author":"DD Patel","year":"2015","unstructured":"Patel DD, Modi KP, Patel AK, Chaudhary V. New onset of diabetes mellitus in Indian renal transplant recipient-a retrospective study. Age. 2015;34:11\u20132.","journal-title":"Age."},{"issue":"1","key":"2052_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12882-018-1171-3","volume":"20","author":"AM Ussif","year":"2019","unstructured":"Ussif AM, \u00c5sberg A, Halden TA, Nordheim E, Hartmann A, Jenssen T. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation. BMC Nephrol. 2019;20(1):12.","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-02052-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T08:46:13Z","timestamp":1723538773000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02052-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02052-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Research and Ethics Committee of the Ministry of Health Malaysia (reference no NMMR-14-1527-21690 (IIR) and conformed with the ethical regulations of the World Medical Association and the Declaration of Helsinki. Written informed consent was obtained from the patients prior to their participation in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}